Cost effectiveness of increasing the dose intensity of chemotherapy with granulocyte colony-stimulating factor in small-cell lung cancer : Based on data from the medical research council LU19 trial

The use of granulocyte colony-stimulating factor (G-CSF) can enable dose intensification of chemotherapy in small-cell lung cancer (SCLC). However, given its acquisition cost, it is important to assess its cost effectiveness within a resource-constrained health service. To assess the cost effectiven...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2006-01, Vol.24 (5), p.443-452
Hauptverfasser:	BOJKE, Laura, SCULPHER, Mark, STEPHENS, Richard, WENDI QIAN, THATCHER, Nick, GIRLING, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - economics Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma, Small Cell - drug therapy Carcinoma, Small Cell - economics Carcinoma, Small Cell - mortality Cost-Benefit Analysis Cost-effectiveness Cost-utility Cyclophosphamide Cyclophosphamide - administration & dosage Cyclophosphamide - economics Dose-Response Relationship, Drug Doxorubicin Doxorubicin - administration & dosage Doxorubicin - economics Etoposide Etoposide - administration & dosage Etoposide - economics Granulocyte Colony-Stimulating Factor - administration & dosage Granulocyte Colony-Stimulating Factor - economics Granulocyte Colony-Stimulating Factor - pharmacology Humans Lenograstim Lung Neoplasms - drug therapy Lung Neoplasms - economics Lung Neoplasms - mortality Medical sciences Middle Aged Neutropenia Pharmacology. Drug treatments Pneumology Quality-Adjusted Life Years Randomized Controlled Trials as Topic Retrospective Studies Small-cell-lung-cancer State Medicine - economics Survival Analysis Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!